Luca Testa

12.9k total citations · 1 hit paper
171 papers, 3.8k citations indexed

About

Luca Testa is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Epidemiology. According to data from OpenAlex, Luca Testa has authored 171 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 134 papers in Cardiology and Cardiovascular Medicine, 78 papers in Surgery and 61 papers in Epidemiology. Recurrent topics in Luca Testa's work include Cardiac Valve Diseases and Treatments (86 papers), Coronary Interventions and Diagnostics (68 papers) and Infective Endocarditis Diagnosis and Management (57 papers). Luca Testa is often cited by papers focused on Cardiac Valve Diseases and Treatments (86 papers), Coronary Interventions and Diagnostics (68 papers) and Infective Endocarditis Diagnosis and Management (57 papers). Luca Testa collaborates with scholars based in Italy, United States and United Kingdom. Luca Testa's co-authors include Giuseppe Biondi‐Zoccai, Pierfrancesco Agostoni, Francesco Bedogni, Antonio Abbate, Marzia Lotrionte, Francesco Burzotta, Filippo Crea, Felicita Andreotti, Imad Sheiban and Azeem Latib and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Luca Testa

156 papers receiving 3.7k citations

Hit Papers

A systematic review and meta-analysis on the hazards of d... 2006 2026 2012 2019 2006 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50 279 patients at risk for coronary artery disease
    2006 512 citations Giuseppe Biondi‐Zoccai, Pierfrancesco Agostoni et al. European Heart Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luca Testa Italy 32 3.1k 1.6k 935 781 725 171 3.8k
Roberto Kalil Filho Brazil 33 2.1k 0.7× 1.1k 0.7× 814 0.9× 840 1.1× 497 0.7× 276 4.5k
Anju Nohria United States 43 4.6k 1.5× 913 0.6× 338 0.4× 1.0k 1.3× 1.4k 1.9× 149 6.8k
Hisham Dokainish United States 32 8.4k 2.7× 1.4k 0.9× 1.1k 1.1× 2.9k 3.7× 1.2k 1.6× 87 9.8k
Peter Sinnaeve Belgium 33 3.2k 1.0× 1.2k 0.8× 425 0.5× 564 0.7× 388 0.5× 174 4.8k
Julia Mascherbauer Austria 32 4.8k 1.6× 1.2k 0.8× 1.2k 1.3× 1.5k 2.0× 1.3k 1.8× 170 6.7k
Antonino Buffon Italy 29 2.3k 0.8× 2.0k 1.2× 794 0.8× 873 1.1× 448 0.6× 71 3.9k
Robert L. Feldman United States 38 3.3k 1.1× 2.1k 1.3× 257 0.3× 2.2k 2.8× 939 1.3× 172 5.0k
Leonardo De Luca Italy 33 2.9k 0.9× 1.6k 1.0× 438 0.5× 643 0.8× 666 0.9× 241 4.3k
Peter Rickenbacher Switzerland 28 3.1k 1.0× 2.1k 1.3× 556 0.6× 533 0.7× 627 0.9× 64 4.5k
Nicolas Méneveau France 35 3.5k 1.1× 1.8k 1.1× 633 0.7× 968 1.2× 809 1.1× 149 5.1k

Countries citing papers authored by Luca Testa

Since Specialization
Citations

This map shows the geographic impact of Luca Testa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Testa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Testa more than expected).

Fields of papers citing papers by Luca Testa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca Testa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Testa. The network helps show where Luca Testa may publish in the future.

Co-authorship network of co-authors of Luca Testa

This figure shows the co-authorship network connecting the top 25 collaborators of Luca Testa. A scholar is included among the top collaborators of Luca Testa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca Testa. Luca Testa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moscarella, Elisabetta, Alfonso Ielasi, Won‐Keun Kim, et al.. (2025). Balloon‐Expandable Myval Octacor Versus Self‐Expanding Evolut PRO/PRO+ and Acurate Neo2: Short‐Term Outcomes From Propensity‐Matched Analysis. Catheterization and Cardiovascular Interventions. 106(5). 2949–2957.
2.
Sturla, Francesco, Enrico Poletti, Emiliano Votta, et al.. (2025). Impact of aortic landing zone geometry on TAVI implantation depth: comparison between ACURATE neo2 and Portico/Evolut. Open Heart. 12(1). e003181–e003181.
3.
Criscione, Enrico, Matteo Casenghi, Federico De Marco, et al.. (2025). The NavIIgister: Transcatheter Aortic Valve Implantation With the Navitor Platform in Bicuspid Anatomy. Catheterization and Cardiovascular Interventions. 106(6). 3265–3270.
4.
Tretter, Justin T., Mackram F. Eleid, Francesco Bedogni, et al.. (2025). Preprocedural CT and ECG Markers for Predicting Post-TAVR Pacemaker Requirement in High-Risk Patients. Structural Heart. 9(11). 100726–100726.
5.
Testa, Luca, Irene Bossi, Ignacio Sánchez Pérez, et al.. (2024). Safety and efficacy of single antiplatelet therapy in a large cohort of patients treated with sirolimus-coated balloon: Post hoc analysis from the prospective EASTBOURNE registry. Cardiovascular revascularization medicine. 74. 52–56. 2 indexed citations
6.
Pivato, Carlo Andrea, Giulio Stefanini, Daniele Giacoppo, et al.. (2024). One-month DAPT after biodegradable-polymer everolimus-eluting stent implantation in patients at high-bleeding risk: an individual patient data pooled analysis of the SENIOR and POEM trials. European Heart Journal Open. 4(4). oeae068–oeae068.
7.
Chiarito, Mauro, Pier Pasquale Leone, Luca Testa, et al.. (2023). Randomized clinical trial of abluminus DES+ sirolimus‐eluting stent versus everolimus‐eluting DES for percutaneous coronary intervention in patients with diabetes mellitus: An optical coherence tomography study. Catheterization and Cardiovascular Interventions. 102(6). 1020–1033. 1 indexed citations
8.
Rubbio, Antonio Popolo, Luca Testa, Carmelo Grasso, et al.. (2022). Transcatheter edge-to-edge mitral valve repair in atrial functional mitral regurgitation: insights from the multi-center MITRA-TUNE registry. CINECA IRIS Institutial research information system (University of Pisa). 30 indexed citations
9.
Crimi, Gabriele, Vincenzo De Marzo, Federico De Marco, et al.. (2022). Acute Kidney Injury After Transcatheter Aortic Valve Replacement Mediates the Effect of Chronic Kidney Disease. Journal of the American Heart Association. 11(19). e024589–e024589. 13 indexed citations
10.
Basavarajaiah, Sandeep, Alfonso Ielasi, Luca Testa, et al.. (2022). Long‐term outcomes following intravascular lithotripsy (IVL) for calcified coronary lesions: A Real‐World Multicenter European Study. Catheterization and Cardiovascular Interventions. 101(2). 250–260. 10 indexed citations
11.
Rubbio, Antonio Popolo, Luca Testa, Federico De Marco, et al.. (2021). Prognostic significance of right ventricle to pulmonary artery coupling in patients with mitral regurgitation treated with the MitraClip system. Catheterization and Cardiovascular Interventions. 99(4). 1277–1286. 13 indexed citations
12.
Latib, Azeem, Pierfrancesco Agostoni, Jo Dens, et al.. (2021). Paclitaxel Drug-Coated Balloon for the Treatment of De Novo Small-Vessel and Restenotic Coronary Artery Lesions: 12-Month Results of the Prospective, Multicenter, Single-Arm PREVAIL Study. ˜The œJournal of invasive cardiology. 33(11). E863–E869. 6 indexed citations
13.
Dall’Ara, Gianni, Luca Testa, Carlo Tumscitz, et al.. (2020). No-Reflow Complicating Chronic Total Occlusion Coronary Revascularization. ˜The œJournal of invasive cardiology. 32(2). 58–63. 3 indexed citations
14.
Adamo, Marianna, Claudia Fiorina, Cristina Giannini, et al.. (2020). Interaction between severe chronic kidney disease and acute kidney injury in predicting mortality after transcatheter aortic valve implantation: Insights from the Italian Clinical Service Project. Catheterization and Cardiovascular Interventions. 96(7). 1500–1508. 5 indexed citations
15.
Aziz, Amir, Gurbir Bhatia, Anirban Choudhury, et al.. (2020). Intravascular lithotripsy in calcified‐coronary lesions: A real‐world observational, European multicenter study. Catheterization and Cardiovascular Interventions. 98(2). 225–235. 26 indexed citations
16.
Demir, Ozan M., Satoru Mitomo, Antonio Mangieri, et al.. (2019). Diagnostic Accuracy of Microcatheter Derived Fractional Flow Reserve. The American Journal of Cardiology. 124(2). 183–189. 2 indexed citations
17.
Adamo, Marianna, Claudia Fiorina, Anna Sonia Petronio, et al.. (2018). Comparison of Early and Long-Term Outcomes After Transcatheter Aortic Valve Implantation in Patients with New York Heart Association Functional Class IV to those in Class III and Less. The American Journal of Cardiology. 122(10). 1718–1726. 6 indexed citations
18.
Latini, Roberto Adriano, et al.. (2016). Valve-in-valve di bioprotesi aortica disfunzionante (Biocor) trattata mediante impianto di valvola Portico. Giornale italiano di cardiologia. 17(4). 273–6. 1 indexed citations
19.
20.
Gaal, William J. van, Luca Testa, Theodoros D. Karamitsos, et al.. (2009). Myocardial injury following coronary artery bypass surgery compared with percutaneous coronary angioplasty (MICASA) trial. A randomised controlled trial using magnetic resonance imaging. European Heart Journal. 30. 872–873. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roberto Kalil Filho Breakdown of academic impact, for papers by Anju Nohria Breakdown of academic impact, for papers by Hisham Dokainish Breakdown of academic impact, for papers by Peter Sinnaeve Breakdown of academic impact, for papers by Julia Mascherbauer Breakdown of academic impact, for papers by Antonino Buffon Breakdown of academic impact, for papers by Robert L. Feldman Breakdown of academic impact, for papers by Leonardo De Luca Breakdown of academic impact, for papers by Peter Rickenbacher Breakdown of academic impact, for papers by Nicolas Méneveau
Rankless by CCL
2026